New York Office
6900 Jericho Turnpike
Syosset, NY 11791
516.822.3550
Fax: 516.822.3582
Irving N. Feit
Irving N. Feit, J.D., St. John’s University School of Law, 1979; Post-doctoral Research Fellow, University of California, 1969-1970; Ph.D., Chemistry, University of Rochester, 1969; B.S., Chemistry, University of Rhode Island, 1964. Admitted to practice before the state courts of New York; registered to practice before the United States Patent and Trademark Office. Vice President, Intellectual Property and Licensing, ImClone Systems Incorporated, 1990-1995; Associate, Hoffmann & Baron, LLP, 1988-1989; Biotechnology Patent Counsel, CIBA-GEIGY Corporation, 1982-1988; Patent Counsel, Lever Brothers Company, 1980-1982; Associate Professor of Chemistry, C.W. Post College of Long Island University, 1970-1979.
Extensive articles and lectures: “When Can A Licensee Challenge A Licensed Patent? The Supreme Court Shocks the Technology Transfer Community in MedImmune v. Genentech,” les Nouvelles, September 2007; “Can a Patent Claim that Refers to Another Claim be Independent? Pfizer v. Ranbaxy Laboratories Reconsidered,” Journal of the Patent and Trademark Office Society, September 2007 (with Tony A. Gayoso); "Must Utility Be Unquestionable at the Time of Filing a Patent Application under the Enablement Requirement of §112?," Intellectual Property Today, December 2005 (with James F. Harrington); "Setting the course for claim construction," Managing Intellectual Property , September 2005; "The Safe Harbor Infringement Exemption Under the Hatch-Waxman Act, Finally Defined," Intellectual Property Today, August 2005; "Protect Yourself: Intellectual Property 101," New Jersey TechNews, April 2005; "The Written Description Requirement: Enzo Biochem v. Gen-Probe Reheard and Reconsidered," Intellectual Property Today, February 2003; "Inherency in Patent Law," Journal of the Patent and Trademark Office Society, January 2003 (with Christina L. Warrick); "Provisional Patent Application, Reality and Myth," Intellectual Property Today, December 2002 (with Lauren T. Emr); “The Written Description Requirement for Biotechnology Inventions in the Federal Circuit," Intellectual Property Today, July 2002; "Recent Developments in Patent Law and Their Effect on the Value of IP," Licensing Executives Society Annual Meeting, October 17, 2005; "The Hatch-Waxman Act and Patents that Cover Research and Screening for Drugs," Licensing Executives Society Annual Meeting, September 23, 2003 (with Lauren T. Emr); “Biotechnology Research and the Experimental Use Exception to Patent Infringement,” American Bar Association, Section of Patent, Trademark, and Copyright Law, April 5, 1990.
Experienced in patent prosecution, interference practice, licensing, and negotiations.
Fields of technology include the chemical and biotechnological arts.
DISCLAIMER
Attorney Advertisement
© 2001 - 2010 Hoffmann & Baron, LLP
All Rights Reserved